KDx Selects Acupath as Lab for URO17™ FDA Clinical Trial ...Middle East

PR Newswire - News
PLAINVIEW, N.Y. and CAMPBELL, Calif., Nov. 6, 2020 /PRNewswire/ -- Acupath Laboratories, Inc., a leading provider of sub-specialized anatomic and molecular pathology services, and KDx Diagnostics, Inc., a leading developer of bladder cancer tests, today announced that KDx has selected...

Read More Details
Finally We wish PressBee provided you with enough information of ( KDx Selects Acupath as Lab for URO17™ FDA Clinical Trial )

Apple Storegoogle play

Also on site :